Skip to content
The Nexus
SCIENCEJul 16 · 00:00 UTCNEW SCIENTISTGeorgia Hill

Drug discovery Is changing. Drug development must change too.

Artificial intelligence and big data are accelerating drug discovery, creating a mismatch with existing manufacturing capabilities for safe mass production. Experts from Cytiva highlight challenges in scaling purification processes from lab to industrial scales, emphasizing the risks and complexities in translating promising drug candidates to market-ready therapies.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting